Related Experiment Videos
Does blood transfusion predispose to cancer recurrence?
1Department of Surgery, Mount Sinai Medical Center, New York, New York 10029.
American Journal of Clinical Oncology
|April 1, 1989
Summary
Studies on perioperative blood transfusions and cancer recurrence lack sufficient data and controls. Current evidence does not support specific recommendations for blood use in cancer patients due to methodological limitations.
Area of Science:
- Oncology
- Transfusion Medicine
- Surgical Oncology
Background:
- The relationship between perioperative blood transfusion and cancer recurrence is a significant concern in surgical oncology.
- Existing retrospective studies present conflicting findings regarding this association.
Purpose of the Study:
- To review and critically evaluate retrospective studies examining the link between perioperative blood transfusion and cancer recurrence.
- To identify limitations in current research and assess the validity of existing conclusions.
Main Methods:
- Comprehensive review of retrospective studies on perioperative blood transfusion and cancer recurrence.
- Analysis of methodological quality, focusing on control for confounding variables.
- Assessment of statistical power in studies comparing transfused and untransfused patients.
Main Results:
- The majority of reviewed studies lacked adequate control for crucial confounding variables (e.g., anemia, surgical complexity, disease stage).
- No studies possessed sufficient sample size for statistically valid conclusions regarding transfused versus untransfused patients.
- Significant heterogeneity and lack of consensus were observed across the studies.
Conclusions:
- Current retrospective evidence on perioperative blood transfusion and cancer recurrence is methodologically flawed.
- No definitive conclusions can be drawn, and no recommendations for blood product use in cancer patients are justified based on these studies.